Anlon Healthcare

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
28.20
1.34 (4.99%)
BSENSE

Oct 09

BSE+NSE Vol: 2.37 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lincoln Pharma.
Kopran
Jagsonpal Pharma
Anlon Healthcare
Sigachi Indust.
Hester Bios
Fermenta Biotec.
Bajaj Healthcare
Amrutanjan Healt
Bharat Parenter.
Accent Microcell
Why is Anlon Healthcare Ltd ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Anlon Healthcare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
9.26
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
30.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.89%
ROCE (avg)
9.07%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
58
Industry P/E
36
Price to Book Value
7.15
EV to EBIT
33.65
EV to EBITDA
32.53
EV to Capital Employed
6.12
EV to Sales
8.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
17.78%
ROE (Latest)
13.85%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NET SALES(9M)

At Rs 121.98 cr has Grown at 33.18%

-9What is not working for the Company
PAT(Q)

At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average

NET SALES(Q)

Lowest at Rs 30.98 cr

Loading Valuation Snapshot...
Here's what is not working for Anlon Healthcare
Net Sales - Quarterly
At Rs 30.98 cr has Fallen at -29.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 44.13 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 4.80 cr has Fallen at -31.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.95 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 30.98 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)